Ladenburg Thalmann Downgrades Zosano Pharma (ZSAN) to Neutral
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Ladenburg Thalmann downgraded Zosano Pharma (NASDAQ: ZSAN) from Buy to Neutral.
Shares of Zosano Pharma closed at $1.39 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Downgrades Dynegy (DYN) to Sell
- Jefferies Downgrades Alcobra Ltd. (ADHD) to Hold
- Credit Suisse Downgrades Himax Technologies (HIMX) to Neutral
Create E-mail Alert Related CategoriesDowngrades
Related EntitiesLadenburg Thalmann Financial Services
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!